These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21810054)

  • 21. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rising standards for tuberculosis drug development.
    Balganesh TS; Alzari PM; Cole ST
    Trends Pharmacol Sci; 2008 Nov; 29(11):576-81. PubMed ID: 18799223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical testing of new drugs for tuberculosis: current challenges.
    Lenaerts AJ; Degroote MA; Orme IM
    Trends Microbiol; 2008 Feb; 16(2):48-54. PubMed ID: 18182291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mathematical modeling of pulmonary tuberculosis therapy: Insights from a prototype model with rifampin.
    Goutelle S; Bourguignon L; Jelliffe RW; Conte JE; Maire P
    J Theor Biol; 2011 Aug; 282(1):80-92. PubMed ID: 21605569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis.
    Törün T; Tahaoğlu K; Ozmen I; Sevim T; Ataç G; Kir A; Güngör G; Bölükbaşi Y; Maden E
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):979-85. PubMed ID: 17705975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspective.
    Sacks LV; Behrman RE
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S93-100. PubMed ID: 18762157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.
    Tabarsi P; Chitsaz E; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Amiri M; Mansouri D; Masjedi MR; Velayati AA; Caminero JA
    Microb Drug Resist; 2010 Mar; 16(1):81-6. PubMed ID: 20192820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole blood bactericidal activity during treatment of pulmonary tuberculosis.
    Wallis RS; Vinhas SA; Johnson JL; Ribeiro FC; Palaci M; Peres RL; Sá RT; Dietze R; Chiunda A; Eisenach K; Ellner JJ
    J Infect Dis; 2003 Jan; 187(2):270-8. PubMed ID: 12552451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Initial drug resistance as a threat for tuberculosis control: the case of Buenaventura, Colombia].
    Moreira CA; Hernández HL; Arias NL; Castaño MC; Ferro BE; Jaramillos E
    Biomedica; 2004 Jun; 24 Supp 1():73-9. PubMed ID: 15495574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs.
    Abate G; Miörner H; Ahmed O; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):580-4. PubMed ID: 9661826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging drugs for active tuberculosis.
    Ginsberg AM
    Semin Respir Crit Care Med; 2008 Oct; 29(5):552-9. PubMed ID: 18810688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug repositioning in the treatment of malaria and TB.
    Nzila A; Ma Z; Chibale K
    Future Med Chem; 2011 Sep; 3(11):1413-26. PubMed ID: 21879845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of delayed treatment response in pulmonary tuberculosis: use of time to positivity values of Bactec cultures.
    Carroll NM; Uys P; Hesseling A; Lawrence K; Pheiffer C; Salker F; Duncan K; Beyers N; van Helden PD
    Tuberculosis (Edinb); 2008 Nov; 88(6):624-30. PubMed ID: 18456556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China.
    Qi W; Harries AD; Hinderaker SG
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):137-9. PubMed ID: 21276311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
    Fattorini L; Migliori GB; Cassone A
    Ann Ist Super Sanita; 2007; 43(4):317-9. PubMed ID: 18209265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The search for new sterilizing anti-tuberculosis drugs.
    Mitchison DA
    Front Biosci; 2004 May; 9():1059-72. PubMed ID: 14977529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis.
    Franzblau SG; DeGroote MA; Cho SH; Andries K; Nuermberger E; Orme IM; Mdluli K; Angulo-Barturen I; Dick T; Dartois V; Lenaerts AJ
    Tuberculosis (Edinb); 2012 Nov; 92(6):453-88. PubMed ID: 22940006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.